Findings from a recently presented study demonstrated that patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors (GEP-NETs) may benefit from treatment with Afinitor ...

Cipla's Q3FY25 revenue is expected to grow 3.1-7%, with profit estimates ranging from a 2.2% decline to 14% growth.

Adding the somatostatin analog lanreotide to the mTOR inhibitor everolimus significantly prolonged progression-free survival in patients with unresectable or recurrent gastroenteropancreatic ...

The organization that runs a supervised injection site in New Brunswick says their work is saving lives and it's disappointing P.E.I. has decided not to open a similar site for now. P.E.I. health ...

One day after a subcutaneous injection into the left thigh, she developed a mildly pruritic eruption on the right thigh, at the site of a previous injection. Etanercept (Enbrel ®) is an ...

P.E.I.'s chief public health officer says the province has decided to pause the establishment of a supervised injection site and instead prioritize strengthening its existing harm reduction ...

Before injecting Nucala, you’ll need to clean the injection site with an alcohol swab and let it air-dry. Do not touch the injection site again until after your injection. Be sure to avoid ...

Cipla is also gradually building market share in Lanreotide injections. Albuterol, Lanreotide, gRevlimid, and Brovana are projected to contribute stable sales of $238 million in the US market, with ...

The "Lanreotide Injection Market"is anticipated to increase from USD xxx billion in 2023 to USD xxx billion by 2031, with a strong compound annual growth rate (CAGR) of xxx% from 2024 to 2031. This ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.